SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.

Candida krusei is increasingly recognized as an opportunistic pathogen in immunocompromised patients and is inherently resistant to fluconazole. We tested the in vivo efficacy of SCH 51048, an investigational antifungal triazole, in experimental hematogenous murine infection caused by two C. krusei...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Karyotakis, N C, Dignani, M C, Anaissie, E J
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1995
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162625/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7793892/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.39.3.775
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!